C19H19N5O, triclinic, P1̅ (no. 2), a = 11.8865(6) Å, b = 12.6289(7) Å, c = 13.5579(7) Å, α = 74.552(2)°, β = 83.174(2)°, γ = 62.534(2)°, V = 1740.56(16) Å3, Z = 4, Rgt(F) = 0.0610, wRref(F2) = 0.1713, T = 100 K
C34H31N3O, monoclinic, P21/c (no. 14), a = 26.803(5) Å, b = 5.8243(12) Å, c = 16.893(3) Å, β = 98.53...
C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.8...
Crystal structure of the title compound C22H19N3O is determined by single crystal X-ray diffraction ...
C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = ...
C28H19N5O2, monoclinic, Cc (no. 9), a = 13.9896(9) Å, b = 21.9561(14) Å, c = 7.1643(5) Å, β = 91...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97....
C18H15Cl2N3O, monoclinic, P21/c (no. 14), a = 9.370(2) Å, b = 28.367(9) Å, c = 6.7161(16) Å, β = 103...
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C19H17N5O2, monoclinic, C2/c (no. 15), a = 14.734(6) Å, b = 13.565(5) Å, c = 33.385(12) Å, β = 91.31...
International audienceC15H 16 N 2 O 3 , monoclinic, P21/c (no. 14), a = 11.223(2) Å, b = 11.9339(5) ...
C26H19N3OS, monoclinic, P21 (no. 4), a = 13.0921(19) Å, b = 5.6740(8) Å, c = 14.417(2) Å, β = 106...
The title compound, C19H21N3O, comprises a central pyrazole ring which is N-connected to an aldehyde...
C34H31N3O, monoclinic, P21/c (no. 14), a = 26.803(5) Å, b = 5.8243(12) Å, c = 16.893(3) Å, β = 98.53...
C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.8...
Crystal structure of the title compound C22H19N3O is determined by single crystal X-ray diffraction ...
C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = ...
C28H19N5O2, monoclinic, Cc (no. 9), a = 13.9896(9) Å, b = 21.9561(14) Å, c = 7.1643(5) Å, β = 91...
C22H22N2O5, triclinic, P1̅ (no. 2), a = 7.592(2) Å, b = 9.835(3) Å, c = 13.579(4) Å, α = 86.600(3)°,...
C12H11N5O6, triclinic, P1̅ (no. 2), a = 10.4031(5) Å, b = 11.3191(5) Å, c = 13.2540(6) Å, α = 97....
C18H15Cl2N3O, monoclinic, P21/c (no. 14), a = 9.370(2) Å, b = 28.367(9) Å, c = 6.7161(16) Å, β = 103...
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C9H12N2O2, triclinic, P (1) over bar (no. 2), a - 6.6954(7) angstrom, b - 7.6325(8) angstrom, c = 9....
C19H17N5O2, monoclinic, C2/c (no. 15), a = 14.734(6) Å, b = 13.565(5) Å, c = 33.385(12) Å, β = 91.31...
International audienceC15H 16 N 2 O 3 , monoclinic, P21/c (no. 14), a = 11.223(2) Å, b = 11.9339(5) ...
C26H19N3OS, monoclinic, P21 (no. 4), a = 13.0921(19) Å, b = 5.6740(8) Å, c = 14.417(2) Å, β = 106...
The title compound, C19H21N3O, comprises a central pyrazole ring which is N-connected to an aldehyde...
C34H31N3O, monoclinic, P21/c (no. 14), a = 26.803(5) Å, b = 5.8243(12) Å, c = 16.893(3) Å, β = 98.53...
C18H15FN2O2, triclinic, P1̅ (no. 2), a = 7.8272(8) Å, b = 9.6662(10) Å, c = 10.9834(12) Å, α = 107.8...
Crystal structure of the title compound C22H19N3O is determined by single crystal X-ray diffraction ...